Zhejiang Medicine Co.,Ltd.’s Net Profit Dropped 33.4% in First Half of 2022

Zhejiang Medicine Co.,Ltd. (浙江医药股份有限公司) (600216.SH) reported a net profit of 312.3 million yuan in the first half of 2022, down 33.4% year-on-year.

Meanwhile, the company posted 4.1 billion yuan in revenue, down 10.8% year-on-year.

At the end of the reporting period, it had 12.3 billion yuan in total assets and 3.1 billion yuan in total liabilities, with a liability-to-asset ratio of 25.5%.